With the COVID-19 pandemic disrupting global supply chains and forcing many to work from home, life sciences organizations are under pressure to quickly adapt while adhering to rigorous compliance standards.
Please join experts from Thermo Fisher Scientific, Becton Dickinson and DocuSign, as they discuss best practices on the following:
• Digital transformation beyond organizational silos
• Accelerate regulatory and quality processes to adhere to GxP guidelines and global standards such as GDPR and eIDAS
• Quickly stand-up and validate a technology within weeks to adhere to the FDA’s 21 CFR Part 11 requirements
• The challenges and opportunities COVID-19 poses on the life sciences industry
• Implement a technology across your organization and at scale